HighTower Advisors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 112 filers reported holding REVANCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.7%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,321,042
-32.7%
289,801
+48.6%
0.01%
-40.0%
Q2 2023$4,936,000
-49.8%
195,050
-36.1%
0.01%
-52.4%
Q1 2023$9,830,000
+8.4%
305,259
-37.9%
0.02%0.0%
Q4 2022$9,071,000
-60.7%
491,442
-42.6%
0.02%
-66.1%
Q3 2022$23,098,000
+36.5%
855,434
-30.1%
0.06%
+40.9%
Q2 2022$16,917,000
-29.7%
1,224,162
-0.7%
0.04%
-18.5%
Q1 2022$24,047,000
+52.3%
1,233,140
+27.4%
0.05%
+54.3%
Q4 2021$15,793,000
-34.1%
967,718
+12.5%
0.04%
-45.3%
Q3 2021$23,957,000
+38.7%
859,904
+47.6%
0.06%
+28.0%
Q2 2021$17,275,000
-10.0%
582,775
-15.2%
0.05%
-18.0%
Q1 2021$19,202,000
+832.1%
687,015
+845.0%
0.06%
+577.8%
Q4 2020$2,060,000
-15.4%
72,700
-25.0%
0.01%
-25.0%
Q3 2020$2,436,000
+102.8%
96,934
+97.0%
0.01%
+71.4%
Q2 2020$1,201,000
+85.3%
49,200
+12.6%
0.01%
+75.0%
Q1 2020$648,000
-2.6%
43,700
+6.6%
0.00%0.0%
Q4 2019$665,000
+81.2%
41,000
+45.4%
0.00%
+100.0%
Q3 2019$367,000
+4.3%
28,200
+3.7%
0.00%0.0%
Q2 2019$352,000
-14.1%
27,200
+4.6%
0.00%
-33.3%
Q1 2019$410,000
+1.7%
26,000
+30.0%
0.00%0.0%
Q4 2018$403,000
-26.3%
20,000
-9.1%
0.00%
-25.0%
Q3 2018$547,000
-9.4%
22,0000.0%0.00%
-20.0%
Q2 2018$604,000
-10.9%
22,0000.0%0.01%
-16.7%
Q1 2018$678,000
-13.9%
22,0000.0%0.01%0.0%
Q4 2017$787,00022,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders